Skip to navigation
Skip to content
MENU
CRISPR/Cas9
Intellectual Property
Licensing
Express License
Learn
What is CRISPR/Cas9
Knowledge Center
Downloads
Press Releases
Our Team
Contact Us
Press Releases
Press Release
A Year Since BIO
Posted on
11 June 2025
11 June 2025
Press Release
CVC successfully appeals prior CRISPR U.S. patent decision
Posted on
15 May 2025
15 May 2025
Press Release
AI + CRISPR: Powering the 21st Century’s Biological Revolution
Posted on
22 April 2025
22 April 2025
Press Release
ERS Genomics and Jumpcode Genomics sign CRISPR/Cas9 license agreement
Posted on
27 March 2025
27 March 2025
Press Release
European Patent Office Grants CVC Portfolio Key CRISPR Patent
Posted on
26 February 2025
26 February 2025
Press Release
Annual Letter From The CEO
Posted on
28 January 2025
28 January 2025
Press Release
ERS Genomics launches ‘Express License’ platform to democratise access to CRISPR/Cas9
Posted on
13 January 2025
13 January 2025
Article
A Letter from the CEO
Posted on
30 October 2024
28 January 2025
Press Release
ERS Genomics and Université de Montréal sign CRISPR/Cas9 license agreement
Posted on
30 September 2024
30 September 2024
Press Release
ERS Genomics and Medicines Discovery Catapult sign CRISPR/Cas9 license agreement
Posted on
4 September 2024
4 September 2024
Press Release
ERS Genomics and IRBM sign CRISPR/Cas9 license agreement
Posted on
20 May 2024
20 June 2024
Press Release
ERS Genomics appoints John E Milad as Chief Executive Officer
Posted on
13 May 2024
13 May 2024
Press Release
Update: Key Charpentier/Doudna CRISPR patent upheld by China National Intellectual Property Administration
Posted on
1 May 2024
13 May 2024
Press Release
Ricoh and ERS Genomics enter into CRISPR/Cas9 license agreement
Posted on
13 March 2024
13 May 2024
Press Release
ERS Genomics and StemSight sign CRISPR/Cas9 license agreement
Posted on
17 January 2024
13 May 2024
Press Release
Key Charpentier/Doudna CRISPR patent upheld by Japanese Patent Office
Posted on
13 December 2023
13 May 2024
Press Release
New CRISPR/Cas9 Licensing Agreement for ERS Genomics & CHUM Research Centre, Montreal
Posted on
26 October 2023
13 May 2024
Press Release
ERS Genomics Limited (‘ERS’) completes licensing agreement with Syngene International
Posted on
19 October 2023
13 May 2024
Press Release
ERS Genomics & Demeetra Enter Into CRISPR/Cas9 Licensing Agreement
Posted on
14 September 2023
14 September 2023
Press Release
ERS Genomics & AlgenScribe Enter Into CRISPR/Cas9 Licensing Agreement
Posted on
5 September 2023
5 September 2023
load more
[ Placeholder content for popup link ]
WordPress Download Manager - Best Download Management Plugin